This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hypereosinophilic Syndrome
Information about Hypereosinophilic Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hypereosinophilic Syndrome
Most recent studies have shown that Hypereosinophilic Syndrome shares some biological mechanisms with asthma, chronic-eosinophilic-inflammation, chronic-eosinophilic-leukemia, churg-strauss-syndrome, endocarditis, endomyocardial-fibrosis, eosinophilia, eosinophilic-leukemia, fibrosis, heart-failure, idiopathic-hypereosinophilic-syndrome, inflammation, leukemia, malignant-neoplasms, myeloid-leukemia, myeloproliferative-disease, neoplasms, pulmonary-eosinophilia, thrombosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hypereosinophilic Syndrome, and have been seen in publications frequently: Anaphylaxis, Cell Death, Cell Differentiation, Cell Proliferation, Chemotaxis, Coagulation, Cytokine Production, Eosinophil Activation, Eosinophil Degranulation, Eosinophil Development, Eosinophil Differentiation, Hypersensitivity, Immune Response, Inflammatory Response, Localization, Pathogenesis, Phagocytosis, Reverse Transcription, Secretion, Sensitization
Quite a number of genes have been found to play important roles in Hypereosinophilic Syndrome, such as ABL1, BCR, CEL, CSF2, FIP1L1, IL13, IL2, IL3, IL4, IL5, JAK2, KIT, PDGFRA, PDGFRB, PRG2, RNASE3, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.